Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 19,74119,760 of 20,252 grants

Completed TRAINING, INDIVIDUAL
Reducing the Burden of Hepatocellular Carcinoma Among Migrant Populations: Improving prevention and outcomes through disease modeling
NATIONAL CANCER INSTITUTE Mayo Clinic Rochester United States 2021 – 2025

Project Summary Hepatocellular carcinoma (HCC) is the fastest growing cause of cancer mortality in the United States. HCC is preventable, and it disproportionately affects migrants...

$539.7K
USD
Completed NON-SBIR/STTR RPGS
Polyunsaturated fatty acids and colorectal tumor risk: a molecular and genetic epidemiology study
NATIONAL CANCER INSTITUTE Vanderbilt University Medical Center United States 2021 – 2025

PROJECT SUMMARY/ABSTRACT Arachidonic acid, a long-chain ω-6 polyunsaturated fatty acid (PUFA), has been demonstrated to affect carcinogenesis in animal and in vitro studies. The ef...

$2.08M
USD
Completed NON-SBIR/STTR RPGS
Discovering the role of YES1 in triple negative breast cancer
NATIONAL CANCER INSTITUTE Cleveland Clinic Lerner Com-Cwru United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT SRC Family Kinases (SFKs) are a group of 9 non-receptor tyrosine kinases that mediate the effects of many extracellular and intracellular signaling pathway...

$4.38M
USD
Completed TRAINING, INDIVIDUAL
Development of a tumor-activated IL12 prodrug to treat solid tumors
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2025

Project Summary/Abstract: Despite recent advances in cancer immunotherapy, solid tumors remain largely refractory to treatment due to disruption of immune homeostasis by the tumor...

$480.3K
USD
Completed NON-SBIR/STTR RPGS
Delineating developmental programs driving tumorigenesis in triple-negative breast cancer
NATIONAL CANCER INSTITUTE Stanford University United States 2021 – 2026

PROJECT SUMMARY Triple-negative breast cancer (TNBC) is the deadliest and 2nd most common subtype of breast cancer in the United States. Although promising new drugs based on PARP...

$4.9M
USD
Completed NON-SBIR/STTR RPGS
Targeting immune suppressive microenvironment in ATC
NATIONAL CANCER INSTITUTE Sloan-Kettering Inst Can Research United States 2021 – 2026

PROJECT SUMMARY/ABSTRACT Patients with anaplastic thyroid cancer (ATC) have a median survival of 6 months. Chemotherapy in combination with surgery and radiation may modestly exten...

$4.19M
USD
Completed NON-SBIR/STTR RPGS
The role of PARP10 in alleviating replication stress and promoting cellular proliferation and tumorigenesis
NATIONAL CANCER INSTITUTE Pennsylvania State University Hershey Me... United States 2021 – 2026

Project Summary Identification of molecular pathways that are preferentially employed and relied upon by cancer cells compared to normal cells is key to designing novel personalize...

$3.5M
USD
Completed NON-SBIR/STTR RPGS
Targeting vulnerabilities of PPM1D-mutant gliomas
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2021 – 2026

Project Summary/Abstract Diffuse midline gliomas (DMGs) are devastating brain tumors of childhood with no curative treatments. We and others have observed up to 15% of all DMGs to...

$3.83M
USD
Completed TRAINING, INSTITUTIONAL
Integrated Training in Quantitative and Experimental Cancer Systems Biology
NATIONAL CANCER INSTITUTE Oregon Health & Science University United States 2021 – 2026

Project Summary There is an outstanding need for a national cadre of quantitatively sophisticated oncologists, with deep training in both biological aspects of cancer and computati...

$4.38M
USD
Completed OTHER RESEARCH-RELATED
Elucidating USP16 function and probing its DUB activity in Down syndrome leukemia
NATIONAL CANCER INSTITUTE St. Jude Children'S Research Hospital United States 2021 – 2025

Project Summary / Abstract Myelodysplastic syndromes (MDS) are heterogeneous clonal hematopoietic stem and progenitor cell (HSPC) disorders with frequent transformation to acute my...

$902.7K
USD
Completed OTHER RESEARCH-RELATED
Surgical Multispecialty Access to Research in Residency Training (SMART)
NATIONAL CANCER INSTITUTE Northwestern University At Chicago United States 2021 – 2026

SUMMARY Surgeon-scientists are an underrepresented population in academic medicine, and federally funded surgeon- scientist-led research has been in decline over the past decade. S...

$2.48M
USD
Completed NON-SBIR/STTR RPGS
Deciphering the molecular control of intratumoral dendritic cells
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

PROJECT SUMMARY Dendritic cells (DC) have a major influence on tumor immunity. DC depletion abrogates tumor immunity and response to PD1 (αPD1) immunotherapy in many preclinical tu...

$5.2M
USD
Completed NON-SBIR/STTR RPGS
Understanding affective processing of scientific evidence to promote informed choice for breast cancer screening
NATIONAL CANCER INSTITUTE University of Colorado Denver United States 2021 – 2026

Project Summary/Abstract Cancer screening for the right patients at the right level of cancer risk can save lives, but over the last several years many expert groups have de-intens...

$5.97M
USD
Completed NON-SBIR/STTR RPGS
Overcoming the blood-brain barrier with nanoparticle vaccines against gliomas
NATIONAL CANCER INSTITUTE University of Florida United States 2021 – 2026

Project Summary While activated T cells cross the blood-brain barrier (BBB), immunotherapy has yet to be harnessed for targeted therapy due to GBM’s heterogeneity and immunosuppres...

$6.01M
USD
Completed NON-SBIR/STTR RPGS
Investigating Macrophage Molecular and Functional Diversity in Tumor Immunity
NATIONAL CANCER INSTITUTE Icahn School of Medicine At Mount Sinai United States 2021 – 2026

PROJECT SUMMARY Macrophages (MF) are one of the largest immune cell components of tumor lesions, where their numbers can even exceed cancer cells. MF play a key role in shaping the...

$6.64M
USD
Completed NON-SBIR/STTR RPGS
Targeting AR and AR-Variants in Castration-Resistant Prostate Cancer
NATIONAL CANCER INSTITUTE Texas A&M University Health Science Ctr United States 2021 – 2026

Project Summary/Abstract Current AR inhibitors (enzalutamide and abiraterone) inhibit either the conversion of androgen to dihydrotestosterone (DHT), block androgen binding to andr...

$4.33M
USD
Completed NON-SBIR/STTR RPGS
Targeting cholesterol metabolism and replication stress response in cancer therapy
NATIONAL CANCER INSTITUTE Ohio State University United States 2021 – 2026

Project Summary: Lung cancer is the leading cause of cancer deaths in both men and women. Non-small cell lung cancer (NSCLC) accounts for large majority of lung cancer diagnoses, a...

$3.39M
USD
Active NON-SBIR/STTR RPGS
Targeting B7-H3 in ovarian cancer
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2021 – 2027

ABSTRACT Remarkable clinical responses have been reported in B-cell malignancies by adoptive transfer of T cells redirected with a chimeric antigen receptor (CAR) specific for the...

$5.57M
USD
Completed NON-SBIR/STTR RPGS
Bayesian Network-Based Integrative Genomics Methods for Precision Medicine
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2021 – 2026

Project Summary/Abstract Modern multi-platform genomic data sets contain substantial molecular information potentially useful for discovering new precision therapeutic strategies....

$4.2M
USD
Completed NON-SBIR/STTR RPGS
Targeting tumor architecture as a novel therapeutic strategy for pancreatic cancer
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2021 – 2026

Pancreatic ductal adenocarcinoma (PDAC) is one of the most chemorefractory cancers among solid tumors. Even with the most effective chemotherapy (i.e., FOLFIRINOX), only 30% of PDA...

$4.46M
USD